Abstract
Aripiprazole is an atypical antipsychotic approved as an adjunct for inadequate response to antidepressants in the treatment of major depressive disorder. Addition of aripiprazole to escitalopram reverses the inhibitory actions of escitalopram on firing activity of serotonin (5-HT), norepinephrine (NE) and dopamine (DA) neurons. This study investigated the postsynaptic neurotransmission of the previously studied monoamines systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
